AVDL
Avadel Pharmaceuticals plcNASDAQHealthcare$21.64+0.00%ClosedMarket Cap: $2.12B
As of 2026-04-04
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
21.39
P/S
8.55
EV/EBITDA
205.49
DCF Value
$12.00
FCF Yield
1.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
94.5%
Operating Margin
1.8%
Net Margin
-0.1%
ROE
-0.3%
ROA
-0.1%
ROIC
0.3%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $77.5M | $20.0K | $0.00 |
| Q2 2025 | $68.1M | $9.7M | $0.10 |
| Q1 2025 | $52.5M | $-4.9M | $-0.05 |
| Q4 2024 | $50.4M | $-5.0M | $-0.05 |
Analyst Ratings
View AllWells FargoEqual Weight
2025-11-20UBSNeutral
2025-10-28Leerink PartnersMarket Perform
2025-10-23HC Wainwright & Co.Neutral
2025-10-23NeedhamHold
2025-10-22Trading Activity
Insider Trades
View AllWeiss Asset Management LPother: Former 10% Owner
SellWed Feb 18
Weiss Asset Management LP10 percent owner
SellWed Feb 18
Rodriguez Susanofficer: Chief Operating Officer
SellThu Feb 12
Thornton Peter J.director
SellThu Feb 12
Thornton Peter J.director
SellThu Feb 12